advertisement
Your Special Attention For IGR 5-3
Drug-induced glaucomas: mechanism and management
R.C. Tripathi, B.J. Tripathi and C. HaggertyDrug Safety 2003; 26(11): 749-767
Abstract no. 897
"All the drugs that cause all the types of glaucoma."
Progress in the genetics of glaucoma
N. Weisschuh and U. SchieferDevelopments in Ophthalmology 2003; 37: 83-93
Abstract no. 772
"The big three: myocilin, CYP1B1 and OPTD and several other genes in several types of glaucoma."
Recent advances in molecular genetics of glaucoma
K. Ray, A. Mukhopadhyay and M. AcharyaMolecular and Cellular Biochemistry 2003; 253(1/2): 223-231
Abstract no. 771
"An overview by researchers from India on glaucoma genetics (the big three: myocilin, optineurin, CYP1B1)."
The effects of antiglaucoma and systemic medications on ocular blood flow
V.P. Costa, A. Harris, E. Stefansson, J. Flammer, G.K. Krieglstein, N. Orzalesi, A. Heijl, J.P. Renard and L.M. Serra ()Progress in Retinal and Eye Research 2003; 22(6): 769-805
Abstract no. 944
"What do we know about the drug effect on ocular blood flow? As usual longitudinal studies are needed."
Retinal vessel diameters and their associations with age and blood pressure
T.Y. Wong, R. Klein, B.E. Klein, S.M. Meuer and L.D. HubbardInvestigative Ophthalmology and Visual Science 2003; 44(11): 4644-4650
Abstract no. 876
"Beaver Dam data on decreasing arteriolar diameter with age, systemic blood pressure. Venous diameter does relate to age but not to blood pressure."
Physicians are prodigious providers of human and economic value
G.R. BeauchampEvidence Based Eye Care 2003; 4: 184-185
No abstract in IGR
"The economic value of physicians is greatly under appreciated. Evidence based medicine leading to economic value."
Safe and effective
A.P. Schachat, W.A. Chambers, T.J. Liesegang and D.A. AlbertOphthalmology 2003; 110: 2073-2074
No abstract in IGR
"What does it really mean? We need to know that."
Pro: Non-penetrating glaucoma surgery - a fair chance
T. Shaarawy and J. FlammerNo abstract in IGR
Contra: Non-penetrating surgery and filtration
T.S. Dietlein and G.K. KrieglsteinGraefe's Archive for Clinical and Experimental Ophthalmology 2003; 241: 699-702 and 703-704
No abstract in IGR
"An interesting viewpoint of the afficinados and sceptics of NPFS which, by the way, is widely used."
Interventions for angle closure glaucoma: an evidence-based update
S.M. Saw, G. Gazzard and D.S. FriedmanOphthalmology 2003; 110: 1869-1878
Abstract no. 883
"The evidence based state of ACG treatment exists only for peripheral iridectomy/otomy and latanoprost."
Current state and future direction of tele-ophthalmology in Canada
M.N. BurnierCanadian Journal of Ophthalmology 2003; 38: 349-351
No abstract in IGR
"The answer to: who is going to do what, where and how in the diagnosis and follow-up of glaucoma? The most experience is with diabetic retinopathy."
